Levo Therapeutics Patents – Insights & Stats (Updated 2023)

Levo Therapeutics has a total of 40 patents globally, out of which 14 have been granted. Of these 40 patents, more than 82% patents are active. United States of America is where Levo Therapeutics has filed the maximum number of patents, followed by Germany and United Kingdom. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Levo Therapeutics.

Levo Therapeutics was founded in the year 2016. The Company is a biomedical research and development services intended to treat the multisystem neurodevelopmental disorder.

Do read about some of the most popular patents of Levo Therapeutics which have been covered by us in this article and also you can find Levo Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Levo Therapeutics patent portfolio.

How many patents does the founder and the CEO of Levo Therapeutics have?

The founder and CEO Sara Cotter has 3 patents.

How many patents does Levo Therapeutics have?

Levo Therapeutics has a total of 40 patents globally. These patents belong to 5 unique patent families. Out of 40 patents, 33 patents are active.

How Many Patents did Levo Therapeutics File Every Year?

Levo Therapeutics Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantLevo Therapeutics Applications FiledLevo Therapeutics Patents Granted
20233
202242
202143
202015
2019101
20183
201718

How many Levo Therapeutics patents are Alive/Dead?

Levo Therapeutics Patent Portfolio

How Many Patents did Levo Therapeutics File in Different Countries?

Levo Therapeutics Worldwide Patent Filing

Countries in which Levo Therapeutics Filed Patents

CountryPatents
Israel5
Hong Kong (S.A.R.)4
Australia4
Korea (South)3
Mexico2
Japan2
Europe2
New Zealand2
Russia2
United States Of America2
Canada1
Germany1
Spain1
Brazil1
South Africa1
China1
Italy1
Austria1

Where are Research Centres of Levo Therapeutics Patents Located?

R&D Centers of Levo Therapeutics

 List of Levo Therapeutics Patents

Levo Therapeutics PatentsTitle
US10842775B2Methods Of Treating Prader-Willi Syndrome
US20210113521A1Methods Of Treating Prader-Willi Syndrome
EP3478281B1Pde4 Inhibitors For Treating Prader-Willi Syndrome
EP3831376A1Pde4 Inhibitors For Treating Obesity, Schaaf-Yang Syndrome Or Autism Spectrum Disorder
CN109562092BTreatments For Prader-Willi Syndrome
AU2017275652B2Methods Of Treating Prader-Willi Syndrome
AU2019345166B2Stable Intranasal Formulations Of Carbetocin
AU2021245104A1Stable Intranasal Formulations Of Carbetocin
CA3026083A1Methods Of Treating Prader-Willi Syndrome
HK40058348AStable Intranasal Formulations Of Carbetocin
HK40058351ACarbetocin Drug Product And Process For Preparing Same
HK40043015APde4 Inhibitors For Treating Obesity, Schaaf-Yang Syndrome Or Autism Spectrum Disorder
HK40007454A1Pde4 Inhibitors For Treating Prader-Willi Syndrome
JP7329634B2How To Treat Prader-Willi Syndrome
JP7044768B2How To Treat Prader-Willi Syndrome
IL294407APosohodiesterase 4 Inhibitor For Use In A Method Of Terating Diseases Associated With Reduced Pc1 Levels And/Or Activity
IL288813AStable Intranasal Formulations Of Carbetocin
IL281520ACarbetocin Drug Product And Process For Preparing Same
IL281519AStable Intranasal Formulations Of Carbetocin
IL263412AMethods Of Treating Prader-Willi Syndrome
KR102478186B1How To Treat Prader-Willi Syndrome
ES2847126T3Pde4 Inhibitors For The Treatment Of Prader-Willi Syndrome
RU2748294C2Method For Treatment Of Prader-Willi Syndrome
DE602017028957T2Pde4 Inhibitors For The Treatment Of Prader-Willi Syndrome
IT202100001568T2Pde4 Inhibitors For The Treatment Of Prader-Willi Syndrome
MX375277BMethods To Treat Prader-Willi Syndrome
ZA201808607BMethods Of Treating Prader-Willi Syndrome
NZ773548AStable Intranasal Formulations Of Carbetocin
NZ778868AStable Intranasal Formulations Of Carbetocin
RU2021114228ATreatment Of Prader-Willi Syndrome
KR1020210062648ACarbetocin Drug Product And Method For Manufacturing Same
MX2020009939AMethods Of Treating Prader-Willi Syndrome.
BR112018075039A2Prader-Willi Syndrome Treatment Methods
WO2022236296A1Therapy For Treatment Of Prader-Willi Syndrome
WO2020061414A1Stable Intranasal Formulations Of Carbetocin
WO2020061416A1Carbetocin Drug Product And Process For Preparing Same
WO2017210540A1Methods Of Treating Prader-Willi Syndrome
AU2019345313A1Carbetocin Drug Product And Process For Preparing Same
KR1020210062638AStable Intranasal Formulations Of Carbetocine
AT1340122TPde4 Inhibitoren Zur Behandlung Des Prader-Willi-Syndroms

What are Levo Therapeutics’ key innovation segments?

What Technologies are Covered by Levo Therapeutics?

The chart below distributes patents filed by Levo Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Levo Therapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has Levo Therapeutics’ search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Levo Therapeutics?

Related Articles

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.